Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Receives FDA Breakthrough Therapy Designation For Tiratricol

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    15/07/2025 07:08
    July 15 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:

EGETIS RECEIVES FDA BREAKTHROUGH THERAPY DESIGNATION FOR TIRATRICOL FOR MCT8 DEFICIENCY

Source text: ID:nMFN3m2Tc8

Further company coverage: EGTX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news